Cargando…

Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants

Misato Mitochondrial Distribution and Morphology Regulator 1 (MSTO1) is a soluble cytoplasmic protein that regulates mitochondrial dynamics by promoting mitochondrial fusion. Variants in the MSTO1 gene cause a rare disease characterized by early-onset myopathy and cerebellar ataxia, with almost 30 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liqun, Su, Ruiting, Huang, Peng, Li, Xingfang, Xiong, Jie, Xiao, Yangyang, Mao, Dingan, Liu, Lingjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402982/
https://www.ncbi.nlm.nih.gov/pubmed/36035138
http://dx.doi.org/10.3389/fgene.2022.947886
_version_ 1784773266938789888
author Liu, Liqun
Su, Ruiting
Huang, Peng
Li, Xingfang
Xiong, Jie
Xiao, Yangyang
Mao, Dingan
Liu, Lingjuan
author_facet Liu, Liqun
Su, Ruiting
Huang, Peng
Li, Xingfang
Xiong, Jie
Xiao, Yangyang
Mao, Dingan
Liu, Lingjuan
author_sort Liu, Liqun
collection PubMed
description Misato Mitochondrial Distribution and Morphology Regulator 1 (MSTO1) is a soluble cytoplasmic protein that regulates mitochondrial dynamics by promoting mitochondrial fusion. Variants in the MSTO1 gene cause a rare disease characterized by early-onset myopathy and cerebellar ataxia, with almost 30 cases reported worldwide. Here we report a case of a 3-year-old boy with novel heterozygous variants of the MSTO1 gene (c.1A>G (p.M1?) and c.727G>C(p.Ala243Pro)). Sequencing data and subsequent validation show that the two variants were inherited from the mother and father of the patient (both were heterozygous). The clinical features are infancy-onset mental and motor retardation, language disorder, dysarthria, scoliosis, cerebellar atrophy, tremor, lower-extremity muscle weakness, elevated muscle enzymes, extensive myopathy with chronic atrophy, hyperventilation lungs, and previously unreported hairy back and enlarged gastrocnemius. Finally, novel heterozygous MSTO1 variants were discovered in this case, which expands the gene spectrum and clinical phenotype of this type of disease, and provides a new direction for future treatment and research. Then we summarize the mutational spectrum, pathological, clinical features and imaging of MSTO1 variants in a cohort of reported 31 patients and discuss the pathogenesis of MSTO1 in humans.
format Online
Article
Text
id pubmed-9402982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94029822022-08-26 Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants Liu, Liqun Su, Ruiting Huang, Peng Li, Xingfang Xiong, Jie Xiao, Yangyang Mao, Dingan Liu, Lingjuan Front Genet Genetics Misato Mitochondrial Distribution and Morphology Regulator 1 (MSTO1) is a soluble cytoplasmic protein that regulates mitochondrial dynamics by promoting mitochondrial fusion. Variants in the MSTO1 gene cause a rare disease characterized by early-onset myopathy and cerebellar ataxia, with almost 30 cases reported worldwide. Here we report a case of a 3-year-old boy with novel heterozygous variants of the MSTO1 gene (c.1A>G (p.M1?) and c.727G>C(p.Ala243Pro)). Sequencing data and subsequent validation show that the two variants were inherited from the mother and father of the patient (both were heterozygous). The clinical features are infancy-onset mental and motor retardation, language disorder, dysarthria, scoliosis, cerebellar atrophy, tremor, lower-extremity muscle weakness, elevated muscle enzymes, extensive myopathy with chronic atrophy, hyperventilation lungs, and previously unreported hairy back and enlarged gastrocnemius. Finally, novel heterozygous MSTO1 variants were discovered in this case, which expands the gene spectrum and clinical phenotype of this type of disease, and provides a new direction for future treatment and research. Then we summarize the mutational spectrum, pathological, clinical features and imaging of MSTO1 variants in a cohort of reported 31 patients and discuss the pathogenesis of MSTO1 in humans. Frontiers Media S.A. 2022-08-11 /pmc/articles/PMC9402982/ /pubmed/36035138 http://dx.doi.org/10.3389/fgene.2022.947886 Text en Copyright © 2022 Liu, Su, Huang, Li, Xiong, Xiao, Mao and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Liu, Liqun
Su, Ruiting
Huang, Peng
Li, Xingfang
Xiong, Jie
Xiao, Yangyang
Mao, Dingan
Liu, Lingjuan
Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants
title Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants
title_full Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants
title_fullStr Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants
title_full_unstemmed Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants
title_short Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants
title_sort case report: evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous msto1 variants
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402982/
https://www.ncbi.nlm.nih.gov/pubmed/36035138
http://dx.doi.org/10.3389/fgene.2022.947886
work_keys_str_mv AT liuliqun casereportevidencesofmyastheniaandcerebellaratrophyinachinesepatientwithnovelcompoundheterozygousmsto1variants
AT suruiting casereportevidencesofmyastheniaandcerebellaratrophyinachinesepatientwithnovelcompoundheterozygousmsto1variants
AT huangpeng casereportevidencesofmyastheniaandcerebellaratrophyinachinesepatientwithnovelcompoundheterozygousmsto1variants
AT lixingfang casereportevidencesofmyastheniaandcerebellaratrophyinachinesepatientwithnovelcompoundheterozygousmsto1variants
AT xiongjie casereportevidencesofmyastheniaandcerebellaratrophyinachinesepatientwithnovelcompoundheterozygousmsto1variants
AT xiaoyangyang casereportevidencesofmyastheniaandcerebellaratrophyinachinesepatientwithnovelcompoundheterozygousmsto1variants
AT maodingan casereportevidencesofmyastheniaandcerebellaratrophyinachinesepatientwithnovelcompoundheterozygousmsto1variants
AT liulingjuan casereportevidencesofmyastheniaandcerebellaratrophyinachinesepatientwithnovelcompoundheterozygousmsto1variants